Pleiotropic Effects of Immobilized Versus Soluble Recombinant HIV-1 Tat Protein on CD3-Mediated Activation, Induction of Apoptosis, and HIV-1 Long Terminal Repeat Transactivation in Purified CD4+ T Lymphocytes

Journal of Immunology

Volumn 157, Issue 5, 1996, Pages 2216-2224

  Zauli, Giorgio ^a   Gibellini, Davide ^b   Celeghini, Claudio ^a   Mischiati, Carlo ^a   Bassini, Alessandra ^a   La Placa, Michele ^b   Capitani, Silvano ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYL GLYCYL ASPARTYL SERINE; ARGINYL-GLYCYL-ASPARTYL-SERINE; CD3 ANTIGEN; CROSS LINKING REAGENT; HEPARIN; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY; OLIGOPEPTIDE; RECOMBINANT PROTEIN; TRANSACTIVATOR PROTEIN;

ADULT; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL CULTURE; CELL SEPARATION; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; NUCLEOTIDE REPEAT; PHYSIOLOGY; SOLUBILITY; TRANSACTIVATION;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; CELLS, CULTURED; CROSS-LINKING REAGENTS; GENE PRODUCTS, TAT; HEPARIN; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; OLIGOPEPTIDES; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT PROTEINS; REPETITIVE SEQUENCES, NUCLEIC ACID; SOLUBILITY; TRANS-ACTIVATION (GENETICS);

EID: 0030240562     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Jones, K. A., and M. B. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717.
2. Roy, S., U. Delling, C. H. Chen, C. A. Rosen, and N. Sonenberg. 1990. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated transactivation. Genes Dev. 4:1365.
3. Dingwall, C., I. Ernberg, M. J. Gait, S. M. Green, S. Heaphy, J. Karn, A. D. Lowe, M. Singh, M. A. Skinner, and R. Valerio. 1989. HIV-1 tat protein binds transactivation-response region (TAR) in vitro. Proc. Natl. Acad. Sci. USA 86: 6925.
4. Koken, S. E. C., A. E. Greijer, K. Verhoef, J. van Wamel, A. G. Bukrinskaya, and B. Berkout. 1994. Intracellular analysis of in vitro modified HIV Tat protein. J. Biol. Chem. 269:8366.
5. Dang, C. V., and W. M. F. Lee. 1989. Nuclear and nucleolar targeting sequences of c-erb-A, c-myc, N-myc, p53, HPS70, and HIV tat proteins. J. Biol. Chem. 264:18019.
6. Kim, Y. S., and A. T. Panganiban 1993. The full-length Tat protein is required for TAR-independent, posttranscriptional trans activation of human immunodeficiency virus type 1 env gene expression. J. Virol. 67:3739.
7. Huang, L., A. Joshi, R. Willey, J. Orenstein, and K. T. Jeang. 1994. Human immunodenciency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J. 13:2886.
8. Ensoli, B., G. Barillari, S. Zaki Salahuddin, R. C. Gallo, and F. Wong-Stall. 1990. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345:84.
9. Ensoli, B., L. Buonaguro, G. Barillari, V. Fiorelli, R. Gendelman, R. A. Morgan, P. Wingfield, and R. C. Gallo. 1993. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 tat protein on cell growth and viral transactivation. J. Virol. 67:277.
10. Milani, D., G. Zauli, L. M. Neri, M. Marchisio, M. Previati, and S. Capitani. 1993. Influence of the human immunodeficiency virus type 1 tat protein on the proliferation and differentiation of PC12 rat pheochromocytoma cells. J. Gen. Virol. 74:2587.
11. Zauli, G., M. La Placa, M. Vignoli, M. C. Re, D. Gibellini, G. Furlini, D. Milani, M. Marchisio, M. Mazzoni, and S. Capitani. 1995. An autocrine loop of HIV type 1 Tat protein responsible for the improved survival/proliferation capacity of permanently tat-transfected cells and required for optimal human immunodeficiency virus type 1 long terminal repeat transactivating activity. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10:306.
12. Ranki, A., A. Lagerstedt, V. Ovod, E. Aavik, and K. J. E. Krohn. 1994. Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines. Arch. Virol. 139:365.
13. Zauli, G., D. Gibellini, D. Milani, M. Mazzoni, P. Borgatti, M. La Placa, and S. Capitani. 1993. Human immunodenciency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res. 53:4481.
14. Viscidi, R. P., K. Mayur, H. M. Lederman, and A. D. Frankel. 1989. Inhibition of antigen-induced lymphocyte proliferation by tat protein from HIV-1. Science 246:1606.
15. Subramanyam, M., W. G. Gutheil, W. W. Bachovchin, and B. T. Huber. 1993. Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J. Immunol. 150:2544.
16. Chirmule, N., S. Than, S. A. Khan, and S. Pahwa. 1995. Human immunodeficiency virus Tat induces functional unresponsiveness in T cells. J. Virol. 69:492.
17. Westendorp, M. O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K. M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497.
18. Li, C. J., D. J. Friedman, C. Wang, V. Metelev, and A. B. Pardee. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:229.
19. Purvis, S. F., J. W. Jacobberger, R. M. Sramkoski, A. H. Patki, and M. M. Lederman. 1995. HIV type 1 Tat protein induces apoptosis and death in Jurkat cells. AIDS Res. Hum. Retroviruses 11:443.
20. Zauli, G., B. R. Davis, M. C. Re, G. Visani, G. Furlini, and M. La Placa. 1992. Tat protein stimulates production of transforming growth factor-β1 by marrow macrophages: a potential mechanism for HIV-1-induced hematopoietic suppression. Blood 80:3036.
21. Buonaguro, L., G. Barillari, H. K. Chang, C. A. Bohan, V. Kao, R. Morgan, R. C. Gallo, and B. Ensoli. 1992. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokine. J. Virol. 66:7159.
22. Scala, G., M. R. Ruocco, C. Ambrosino, M. Mallardo, V. Giordano, F. Baldassarre, E. Dragonetti, I. Quinto, and S. Venuta. 1994. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 tat protein. J. Exp. Med. 179:961.
23. Westendorp, M. O., M. Li-Weber, R. W. Frank, and P. H. Krammer. 1994. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J. Virol. 68:4177.
24. Sharma, V., T. J. Knobloch, and D. Benjamin. 1995. Differential expression of cytokine genes in HIV-1 tat transfected T and B cell lines. Biochem. Biophys. Res. Commun. 208:704.
25. Zauli, G., D. Gibellini, A. Caputo, A. Bassini, M. Negrini, M. Monne, M. Mazzoni, and S. Capitani. 1995. The human immunodeficiency virus type-1 (HIV-1) Tat protein upregulates Bcl-2 gene expression in Jurkat T cell lines and primary peripheral blood mononuclear cells. Blood 86:3823.
26. Flores, S. C., J. C. Marecki, K. P. Harper, S. K. Bose, S. K. Nelson, and J. M. McCord. 1993. Tat protein of HIV-1 represses expression of manganese superoxide dismutase in HeLa cells. Proc. Natl. Acad. Sci. USA 90:7632.
27. Li, C. J., C. Wang, D. J. Friedman, and A. B. Pardee. 1995. Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 92:5461.
28. Steinaa, L., A. M. Serensen, J. O. Nielsen, and J. E. S. Hansen. 1994. Antibody to HIV-1 Tat protein inhibits the replication of virus in culture. Arch. Virol. 139:263.
29. Re, M. C., G. Furlini, M. Vignoli, E. Ramazzotti, G. Roderigo, V. De Rosa, G. Zauli, S. Lolli, S. Capitani, and M. La Placa. 1995. Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10:408.
30. Frankel, A. D., and C. O. Pabo. 1988. Cellular uptake of the Tat protein from human immunodeficiency virus. Cell 55:1189.
31. Mann, D. A., and A. D. Frankel. 1991. Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. 10:1733.
32. Bonifaci, N., R. Sitia, and A. Rubartelli. 1995. Nuclear translocation of an exogenous fusion protein containing HIV Tat requires unfolding. AIDS 9:995.
33. Fawell, S., J. Seery, Y. Daikh, C. Moore, L. L. Chen, B. Pepinsky, and J. Barsoum. 1994. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA 91:664.
34. Brake, D. A., C. Debouck, and G. Biesecher. 1990. Identification of an Arg-Gly-Asp (RGD) cell adhesion site in human immunodeficiency virus type I transactivation protein, tat. J. Cell Biol. 111:1275.
35. Barillari, G., R. Gendelman, R. C. Gallo, and B. Ensoli. 1993. The tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same types by using integrin receptors recognizing RGD amino acid sequence. Proc. Natl. Acad. Sci. USA 90:7941.
36. 5 integrin to the basic domain of the HIV tat protein and vitronectin. J. Cell Biol. 121:461.
37. Weeks, B. S., K. Desai, P. M. Loewenstein, M. E. Klotman, P. Klotman, M. Green, and H. K. Kleinman. 1993. Identification of a novel cell attachment domain in the HIV-1 Tat protein and its 90-kDa cell surface binding protein. J. Biol. Chem. 268:5279.
38. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493.
39. Crabtree, G. R., and N. A. Clipstone. 1994. Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu. Rev. Biochem. 63:1045.
40. Matsuyama, T., A. Yamada, J. Kay, K. M. Yamada, S. K. Akiyama, S. F. Schlossman, and C. Morimoto. 1990. Activation of CD4 cells by fibronectin and anti-CD3 antibody: a synergistic effect mediated by the VLA-5 fibronectin receptor complex. J. Exp. Med. 170:1133.
41. Boise, L. H., A. J. Minn, C. H. June, T. Lindsten, and C. B. Thompson. 1995. Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. Proc. Natl. Acad. Sci. USA 92:5491.
42. Cardarelli, P. M., and M. D. Peirschbacher. 1987. Identification of fibronectin receptors on T lymphocytes. J. Cell Biol. 105:495.
43. Ruoslati, E., and M. D. Pierschbacher. 1986. Arg-Gly-Asp: a versatile cell recognition signal. Cell 44:517.
44. Albini, A., G. Fontanini, L. Masiello, C. Tacchetti, D. Bigini, P. Luzzi, D. M. Noonan, and W. G. Stetler-Stevenson. 1994. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. AIDS 8:1237.
45. Helland, D. E., J. L. Welles, A. Caputo, and W. A. Haseltine. 1991. Transcellular transactivation by the human immunodeficiency virus type 1 tat protein. J. Virol. 65:4547.
46. Marcuzzi, A., J. Weinberger, and O. K. Weinberger. 1992. Transcellular activation of the human immunodeficiency virus type 1 long terminal repeat in cocultured lymphocytes. J. Virol. 66:4228.
47. Thomas, C. A., J. Dobkin, and O. K. Weinberger. 1994. Tat-mediated transcellular activation of HIV-1 long terminal repeat directed gene expression by HIV-1-infected peripheral blood mononuclear cells. J. Immunol. 153:3831.
48. Jeang, K. T., R. Chun, N. H. Lin, A. Gatignol, C. Glabe, and H. Fan. 1993. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J. Virol. 67:6224.
49. Kashanchi, F., G. Piras, M. F. Radonovich, J. F. Duvall, A. Fattaey, C. M. Chiang, R. G. Roeder, and J. N. Brady. 1994. Direct interaction of human TFIID with the HIV-1 transactivator Tat. Nature 367:295.
50. Yu, L., P. M. Loewenstein, Z. Zhang, and M. Green. 1995. In vitro interaction of the human immunodeficiency virus type 1 Tat transactivator and the general transcription factor TFIIB with the cellular protein TAP. J. Virol. 69: 3017.
51. Kabelitz, D., T. Pohl, and K. Pechhold. 1993. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol. Today 14:338.
52. Green, D. R., and D. W. Scott. 1994. Activation-induced apoptosis in lymphocytes. Curr. Biol. 6:476.
53. Bretscher, P., and M. Cohn. 1970. A theory of self-nonself discrimination. Science 169:1042.
54. Guinan, E. C., J. G. Gribben, V. A. Boussiotis, G. J. Freeman, and L. M. Nadler. 1994. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood 84:3261.
55. Clark, E. A., and J. S. Brugge. 1995. Integrins and signal transduction pathways: the road taken. Science 258:233.
56. 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. USA 92:6161.
57. Yamada, A., T. Nikaido, Y. Nojima, S. F. Schlossman, and C. Marimoto. 1991. Activation of human CD4 T lymphocytes: interaction of fibronectin with VLA-5 receptor on CD4 cells induces the AP-1 transcription factor. J. Immunol. 146:53.
58. Juliano, R. L., and J. A. Vamer. 1993. Adhesion molecules in cancer: the role of integrins. Curr. Opin. Biol. 5:812.
59. Denis, M. 1994. Tat protein from HIV-1 binds to Mycobacterium avium via a bacterial integrin: effects on extracellular and intracellular growth. J. Immunol. 153:2072.
60. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123.
61. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type I infection. Nature 373:117.
62. Fauci, A. S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262:1011.
63. Meyaard, L., S. A. Otto, H. Schuitemaker, and F. Miedema. 1992. Effects of HIV-1 Tat protein on human T cell proliferation. Eur. J. Immunol. 22:2729.